Caley Castelein's most recent trade in Whitehawk Therapeutics Inc. was a trade of 1,666,000 Common Stock done at an average price of $2.4 . Disclosure was reported to the exchange on March 4, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Whitehawk Therapeutics Inc. | Caley Castelein | Director | Grant, award, or other acquisition of securities at price $ 2.40 per share. | 04 Mar 2025 | 1,666,000 | 2,165,998 | - | 2.4 | 3,998,400 | Common Stock |
Whitehawk Therapeutics Inc. | Caley Castelein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 45,832 | 45,832 | - | - | Stock Option (right to buy) | |
Tourmaline Bio Inc | Caley Castelein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Whitehawk Therapeutics Inc. | Caley Castelein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 28,255 | 28,255 | - | - | Stock Option (right to buy) | |
Whitehawk Therapeutics Inc. | Caley Castelein | Director | Grant, award, or other acquisition of securities at price $ 12.50 per share. | 26 Sep 2022 | 240,000 | 499,998 | - | 12.5 | 3,000,000 | Common Stock |
Whitehawk Therapeutics Inc. | Caley Castelein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 18,573 | 18,573 | - | - | Stock Option (right to buy) | |
Whitehawk Therapeutics Inc. | Caley Castelein | Director | Purchase of securities on an exchange or from another person at price $ 13.08 per share. | 26 Aug 2021 | 259,998 | 259,998 | - | 13.1 | 3,399,994 | Common Stock |
Whitehawk Therapeutics Inc. | Caley Castelein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 17,549 | 17,549 | - | - | Stock option (right to buy) |